Value of PCR for evaluating occurrence of parasitemia in immunocompromised patients with cerebral and extracerebral toxoplasmosis.

Por Khalifa K el-S, Roth, A, Roth, B, Arasteh, K N, Janitschke, K
Publicado em 1994

48-week efficacy and safety of transitioning virologically stable HIV-1 patients from nevirapine IR 200 mg BID to nevirapine XR 400 mg QD (TRANxITION)

Por Arastéh, K, Ward, A, Plettenberg, A, Livrozet, JM, Cordes, C, Winston, A, Wang, E, Quinson, A
Publicado em 2010

Switch from a ZDV/3TC-based regimen to a completely once daily (QD) regimen of emtricitabine/tenofovir DF fixed dose combination plus a third QD agent (SONETT)

Por Arasteh, K, Weitner, L, Fenske, S, Kuhlmann, B, Freiwald, M, Ebrahimi, R, Gallo, L, Ranneberg, B, Mertenskoetter, T
Publicado em 2009

Potential geographic "hotspots" for drug-injection related transmission of HIV and HCV and for initiation into injecting drug use in New York City, 2011-2015, with implications for...

Por Des Jarlais, D. C., Cooper, H. L. F., Arasteh, K., Feelemyer, J., McKnight, C., Ross, Z.
Publicado no PLoS One (2018)

Intestinal cytomegalovirus disease in immunocompromised patients may be ruled out by search for cytomegalovirus DNA in stool samples.

Por Michel, D, Marre, E, Hampl, W, Roczkos, J, Müller, S, Hertenstein, B, Kern, P, Heymer, B, Salzberger, B, Arasteh, K
Publicado em 1995

Combined HIV Prevention, the New York City Condom Distribution Program, and the Evolution of Safer Sex Behavior among Persons who Inject Drugs in New York City

Por Des Jarlais, D.C., Arasteh, K., Mcknight, C, Feelemyer, J., Hagan, H., Cooper, H. L. F., Perlman, D.C.
Publicado em 2014

Treatment of HIV-related primary central nervous system lymphoma with azt high dose, HAART, interleukin-2 and foscarnet in three patients

Por Marretta, L, Stocker, H, Drauz, D, Mueller, M, Masuhr, A, Dieckmann, S, Wong, V, Koch, A, Grueneisen, A, Arastéh, K, Weiss, R
Publicado em 2011

Safety, Pharmacokinetics, and Efficacy of (+/−)-β-2′,3′-Dideoxy-5-Fluoro-3′-Thiacytidine with Efavirenz and Stavudine in Antiretroviral-Naïve Human Immunodeficiency Virus-Infected...

Por Herzmann, C., Arastèh, K., Murphy, R. L., Schulbin, H., Kreckel, P., Drauz, D., Schinazi, R. F., Beard, A., Cartee, L., Otto, M. J.
Publicado em 2005

High-level sensitivity of quantitative pp65 cytomegalovirus (CMV) antigenemia assay for diagnosis of CMV disease in AIDS patients and follow-up.

Por Bek, B, Boeckh, M, Lepenies, J, Bieniek, B, Arasteh, K, Heise, W, Deppermann, K M, Bornhöft, G, Stöffler-Meilicke, M, Schuller, I, Höffken, G
Publicado em 1996

Quality of T-cell responses versus reduction in viral load: results from an exploratory phase II clinical study of Vacc-4x, a therapeutic HIV vaccine

Por Ellefsen-Lavoie, K, Rockstroh, J, Pollard, R, Pantaleo, G, Podzamczer, D, Asmuth, D, van Lunzen, J, Arastéh, K, Schürmann, D, Peters, B, Clotet, B, Hardy, D, Lazzarin, A, Gatell, J, Sommerfelt, MA, Baksaas, I, Wendel-Hansen, V, Sørensen, B
Publicado em 2012